The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, according to a press release. “This drug takes the first new approach to ...
Each of our cells holds a set of biological instructions (our genes). The creation and growth of cells and the proteins inside of them are activated by our genetics. As we grow during pregnancy, our ...
Schizophrenia medication falls under two main categories: older, first-generation, or "typical" antipsychotics and newer drugs for schizophrenia known as second-generation or "atypical" antipsychotics ...
Stanford Medicine scientists are generating a periodic table of sorts for psychiatric disorders, providing a better understanding of these conditions and paving the way toward targeted treatment. Like ...
The symptoms of schizophrenia vary greatly from person to person, and a newly reported international multicenter study, headed by a research team at the University of Zurich, has found that these ...
Researchers from the Broad Institute of MIT and Harvard, Harvard Medical School, and McLean Hospital have uncovered a strikingly similar suite of changes in gene activity in brain tissue from people ...
Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, according to ...
Today, the Food and Drug Administration approved the first new type of drug for schizophrenia in decades. It's called KarXT, and its main advantage is that it has fewer side effects than current drugs ...